Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Haddad

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|September 2, 2008
Aripiprazole in the treatment of primary delusional parasitosisVinesh Narayan, Muhammad Ashfaq, Peter M Haddad
Patient Related Outcome Measures|July 26, 2014
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategiesPeter M Haddad, Cecilia Brain, Jan Scott
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
Changes in pharmacological treatment for bipolar disorder over time in Manchester: a comparison with Lloyd et al. (2003)Ian M Anderson, Peter M Haddad, Imran Chaudhry
JAMA Psychiatry|November 24, 2021
Limitations in Research on Maintenance Treatment for Individuals With SchizophreniaMikkel Højlund, Peter M Haddad, Christoph U Correll
Journal of Psychopharmacology (Oxford, England)|June 3, 2008
The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised studyAung Tint, Peter M Haddad, Ian M Anderson
The British Journal of Psychiatry. Supplement|November 3, 2009
First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studiesPeter M Haddad, Mark Taylor, Omair S Niaz
Therapeutic Advances in Psychopharmacology|November 1, 2014
A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injectionsAmlan K Das, Abid Malik, Peter M Haddad
BMJ (Clinical Research Ed.)|December 29, 2012
Bipolar disorderIan M Anderson, Peter M Haddad, Jan Scott
Expert Opinion on Drug Metabolism & Toxicology|May 5, 2009
A review of valproate in psychiatric practicePeter M Haddad, Amlan Das, Muhammad Ashfaq, et al.
Therapeutic Advances in Psychopharmacology|July 7, 2018
Rethinking the spectrum of mood disorders: implications for diagnosis and management - Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, FranceRoger S McIntyre, Allan H Young, Peter M Haddad
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
The British Journal of Psychiatry : the Journal of Mental Science|September 2, 2008
Aripiprazole in the treatment of primary delusional parasitosisVinesh Narayan, Muhammad Ashfaq, Peter M Haddad
Patient Related Outcome Measures|July 26, 2014
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategiesPeter M Haddad, Cecilia Brain, Jan Scott
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
Changes in pharmacological treatment for bipolar disorder over time in Manchester: a comparison with Lloyd et al. (2003)Ian M Anderson, Peter M Haddad, Imran Chaudhry
JAMA Psychiatry|November 24, 2021
Limitations in Research on Maintenance Treatment for Individuals With SchizophreniaMikkel Højlund, Peter M Haddad, Christoph U Correll
Journal of Psychopharmacology (Oxford, England)|June 3, 2008
The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised studyAung Tint, Peter M Haddad, Ian M Anderson
The British Journal of Psychiatry. Supplement|November 3, 2009
First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studiesPeter M Haddad, Mark Taylor, Omair S Niaz
Therapeutic Advances in Psychopharmacology|November 1, 2014
A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injectionsAmlan K Das, Abid Malik, Peter M Haddad
BMJ (Clinical Research Ed.)|December 29, 2012
Bipolar disorderIan M Anderson, Peter M Haddad, Jan Scott
Expert Opinion on Drug Metabolism & Toxicology|May 5, 2009
A review of valproate in psychiatric practicePeter M Haddad, Amlan Das, Muhammad Ashfaq, et al.
Therapeutic Advances in Psychopharmacology|July 7, 2018
Rethinking the spectrum of mood disorders: implications for diagnosis and management - Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, FranceRoger S McIntyre, Allan H Young, Peter M Haddad
Pageof 10